[1] Lammert C, Juran BD, Schlicht E, et al. Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients. J Gastroenterol, 2014, 49: 1414-1420.
[2] Chappell LC, Gurung V, Seed PT,et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ, 2012, 344: e3799.
[3] Abu-Hayyeh S, Ovadia C, Lieu T,et al. Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology, 2016, 63: 1287-1298.
[4] Hegade VS, Kendrick SF, Dobbins RL,et al. Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study. Lancet, 2017, 389: 1114-1123. |
